BR9506828A - Composição contendo nebivolol micronizado - Google Patents

Composição contendo nebivolol micronizado

Info

Publication number
BR9506828A
BR9506828A BR9506828A BR9506828A BR9506828A BR 9506828 A BR9506828 A BR 9506828A BR 9506828 A BR9506828 A BR 9506828A BR 9506828 A BR9506828 A BR 9506828A BR 9506828 A BR9506828 A BR 9506828A
Authority
BR
Brazil
Prior art keywords
pct
composition containing
containing micronized
micronized nebivolol
sec
Prior art date
Application number
BR9506828A
Other languages
English (en)
Inventor
Eugeen Jans
Guido Francisco Smans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22731545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9506828(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR9506828A publication Critical patent/BR9506828A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
BR9506828A 1994-02-17 1995-02-10 Composição contendo nebivolol micronizado BR9506828A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19798894A 1994-02-17 1994-02-17
PCT/EP1995/000489 WO1995022325A1 (en) 1994-02-17 1995-02-10 Compositions containing micronized nebivolol

Publications (1)

Publication Number Publication Date
BR9506828A true BR9506828A (pt) 1997-09-30

Family

ID=22731545

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506828A BR9506828A (pt) 1994-02-17 1995-02-10 Composição contendo nebivolol micronizado

Country Status (30)

Country Link
US (1) US5759580A (pt)
EP (1) EP0744946B1 (pt)
JP (1) JP3810079B2 (pt)
KR (1) KR100361636B1 (pt)
CN (1) CN1112921C (pt)
AT (1) ATE212547T1 (pt)
AU (1) AU688860B2 (pt)
BR (1) BR9506828A (pt)
CA (1) CA2182582C (pt)
CY (1) CY2329B1 (pt)
CZ (1) CZ290844B6 (pt)
DE (1) DE69525241T2 (pt)
DK (1) DK0744946T3 (pt)
ES (1) ES2171533T3 (pt)
FI (1) FI117888B (pt)
HU (1) HU221848B1 (pt)
IL (1) IL112659A (pt)
MX (1) MX9603314A (pt)
MY (1) MY115339A (pt)
NO (1) NO314712B1 (pt)
NZ (1) NZ279822A (pt)
PL (1) PL178505B1 (pt)
PT (1) PT744946E (pt)
RU (1) RU2137473C1 (pt)
SG (1) SG47487A1 (pt)
SI (1) SI0744946T1 (pt)
SK (1) SK283250B6 (pt)
TW (1) TW355683B (pt)
WO (1) WO1995022325A1 (pt)
ZA (1) ZA951294B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100264348B1 (ko) * 1994-12-28 2000-08-16 디르크 반테 항-죽종형성제로서 네비볼롤을 함유하는 조성물
US6303147B1 (en) 1995-12-27 2001-10-16 Janssen Pharmaceutica, N.V. Bioadhesive solid dosage form
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
ES2218685T3 (es) * 1997-06-13 2004-11-16 Nanodel Technologies Gmbh Sistema para direccion de farmaco, procedimiento para su preparacion y su utilizacion.
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
US20030152636A1 (en) * 2000-02-23 2003-08-14 Nanopharm Ag Method of treating cancer
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
EP1406608B1 (en) * 2001-05-02 2009-07-29 Nitromed, Inc. Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
EP1741712B1 (en) * 2004-07-30 2011-06-15 Torrent Pharmaceuticals Ltd amorphous form of nebivolol hydrochloride and its preparation
ATE465157T1 (de) * 2004-08-11 2010-05-15 Hetero Drugs Ltd Neues verfahren zur herstellung von nebivololzwischenprodukten
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
EP1848424B1 (en) * 2005-01-31 2017-04-05 Mylan Laboratories, Inc Pharmaceutical composition comprising hydroxylated nebivolol
EP1850842A1 (de) * 2005-02-11 2007-11-07 Stada Arzneimittel Ag Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
WO2007083318A1 (en) * 2006-01-18 2007-07-26 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
EP1839658A1 (en) * 2006-03-30 2007-10-03 Hexal A/S Pharmaceutical composition comprising micronized nebivolol
DE102006036579A1 (de) * 2006-08-04 2008-02-07 Alfred E. Tiefenbacher Gmbh & Co.Kg Pharmazeutische Zusammensetzung
EP1886674B1 (de) * 2006-08-04 2010-03-31 Alfred, E. Tiefenbacher Gmbh & Co. Kg Pharmazeutische Zusammensetzung enthaltend Nebivolol
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
WO2008089549A1 (en) * 2007-01-22 2008-07-31 Genpharm Ulc Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
US20100172972A1 (en) * 2007-05-21 2010-07-08 Sun Pharmaceutical Industries Limited Enteric coated pharmaceutical compositions
CA2637979A1 (en) * 2007-07-26 2009-01-26 Mylan Laboratories, Inc. Treatment of cardiovascular disease in mexican americans using nebivolol
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
WO2009091777A1 (en) * 2008-01-15 2009-07-23 Forest Laboratories Holdings Limited Nebivolol in the treatment of sexual dysfunction
ATE533752T1 (de) 2008-09-08 2011-12-15 Cadila Pharmaceuticals Ltd Verbesserter herstellungsprozess für nebivolol- hydrocholorid
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
KR20110130872A (ko) * 2010-05-28 2011-12-06 현대약품 주식회사 결정형 염산 네비볼롤을 포함하는 약학 조성물 및 제조방법
WO2012003181A2 (en) * 2010-07-02 2012-01-05 Fmc Corporation Solid forms
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
EP3615032A4 (en) * 2017-04-28 2020-12-23 Asana BioSciences, LLC FORMULATIONS, PROCEDURES, KITS AND DOSING FORMS FOR TREATMENT OF ATOPIC DERMATITIS AND IMPROVED STABILITY OF AN ACTIVE INGREDIENT
US20220016025A1 (en) * 2020-07-08 2022-01-20 Vinayak Dinesh DENDUKURI Formulations of nebivolol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60107106A (ja) * 1983-11-15 1985-06-12 Mitsubishi Electric Corp 曲線補間装置
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
JPH02264744A (ja) * 1989-04-04 1990-10-29 Kyowa Hakko Kogyo Co Ltd 光学活性なp―フルオロフェノキシ誘導体およびその製造法

Also Published As

Publication number Publication date
SK105896A3 (en) 1997-05-07
HU9602272D0 (en) 1996-10-28
RU2137473C1 (ru) 1999-09-20
CN1140991A (zh) 1997-01-22
DE69525241D1 (de) 2002-03-14
AU1706895A (en) 1995-09-04
DE69525241T2 (de) 2002-08-29
NZ279822A (en) 1997-04-24
US5759580A (en) 1998-06-02
PT744946E (pt) 2002-07-31
SG47487A1 (en) 1998-04-17
HUT75332A (en) 1997-05-28
EP0744946B1 (en) 2002-01-30
MX9603314A (es) 1997-02-28
FI117888B (fi) 2007-04-13
FI963227A0 (fi) 1996-08-16
CZ234696A3 (en) 1996-11-13
ATE212547T1 (de) 2002-02-15
NO963439L (no) 1996-08-16
SK283250B6 (sk) 2003-04-01
TW355683B (en) 1999-04-11
IL112659A0 (en) 1995-05-26
CA2182582C (en) 2005-03-29
JP3810079B2 (ja) 2006-08-16
EP0744946A1 (en) 1996-12-04
NO314712B1 (no) 2003-05-12
WO1995022325A1 (en) 1995-08-24
DK0744946T3 (da) 2002-05-06
AU688860B2 (en) 1998-03-19
CZ290844B6 (cs) 2002-10-16
IL112659A (en) 1999-06-20
FI963227A (fi) 1996-08-16
KR100361636B1 (ko) 2003-02-11
CN1112921C (zh) 2003-07-02
CA2182582A1 (en) 1995-08-24
CY2329B1 (en) 2004-02-06
SI0744946T1 (en) 2002-06-30
ZA951294B (en) 1996-08-16
ES2171533T3 (es) 2002-09-16
MY115339A (en) 2003-05-31
JPH09508913A (ja) 1997-09-09
PL315973A1 (en) 1996-12-23
PL178505B1 (pl) 2000-05-31
HU221848B1 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
BR9506828A (pt) Composição contendo nebivolol micronizado
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
ATE206123T1 (de) Phenylxanthin-derivate
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
IL114241A0 (en) Thiazolidine derivatives their preparation and compositions containing them
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
FI962323A (fi) N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit
NO307376B1 (no) N-substituerte azabicykloheptan-derivater egnet som neuroleptika
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
IT1274483B (it) Composizioni farmaceutiche contenenti gemfibrozil
NO950177D0 (no) Farmakologisk aktive erivater

Legal Events

Date Code Title Description
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 10/02/2015